Is a 7.5 mg dose of mirtazapine easy to taper off?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tapering Off 7.5mg Mirtazapine

Yes, 7.5mg mirtazapine is relatively easier to taper off compared to higher doses, but you should still taper gradually rather than stop abruptly to minimize withdrawal symptoms.

Why 7.5mg is Easier to Taper

At 7.5mg, you're already at half the typical starting dose (15mg) 1, which means:

  • Lower receptor occupancy: You have less pharmacological effect to reverse, reducing the magnitude of withdrawal
  • Shorter duration of use likely: This dose is often used short-term for sleep or as adjunctive therapy, meaning less physical dependence has developed
  • Smaller absolute reductions needed: You need fewer tapering steps to reach zero

The Critical Caveat: Never Stop Abruptly

Despite the low dose, abrupt discontinuation of mirtazapine can cause significant withdrawal symptoms including dizziness, abnormal dreams, sensory disturbances (paresthesia, electric shock sensations), agitation, anxiety, fatigue, confusion, headache, tremor, nausea, vomiting, and sweating 1. One case report documented severe, recurrent panic attacks lasting 5 days after abrupt cessation of 30mg mirtazapine after only 10 weeks of use 2.

Recommended Tapering Approach

For 7.5mg mirtazapine, taper over 2-4 weeks minimum:

  1. Week 1-2: Reduce to 3.75mg daily (half tablet)
  2. Week 3-4: Reduce to 1.875mg daily (quarter tablet) or every other day dosing of 3.75mg
  3. Week 5: Stop completely

Important Considerations

  • Duration of prior use matters: If you've been on 7.5mg for months or years, extend the taper to 4-8 weeks or longer 3
  • Monitor for withdrawal symptoms: If symptoms emerge, slow the taper rate or pause temporarily 3, 4
  • Avoid alternate-day dosing at standard doses: Recent evidence shows that dosing every other day causes pronounced receptor occupancy variation and increases withdrawal risk 5. Only use alternate-day dosing at the very end of your taper (below 3.75mg)

Practical Implementation

Since 7.5mg tablets may not be easily divisible into smaller doses:

  • Use a pill cutter for 3.75mg and 1.875mg doses
  • Consider liquid formulation if available for more precise micro-dosing at the end of the taper 6, 7
  • Dissolve tablets in water if liquid unavailable (though bioavailability may vary)

When to Seek Help

Contact your physician immediately if you experience:

  • Severe anxiety or panic attacks
  • Persistent insomnia (lasting >3 days)
  • Significant mood changes
  • Physical symptoms that interfere with daily function

The key principle: gradual dose reduction over several weeks minimizes withdrawal effects and maximizes success 3, 1. At 7.5mg, you have the advantage of starting from a low dose, but respect the pharmacology—your brain still needs time to readjust.

References

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Stopping antidepressants: when and how.

Australian prescriber, 2026

Research

Stopping antidepressants safely.

African journal of primary health care & family medicine, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.